Novatox 100 Clostridium botulinum ATCC 3502 100 IU – KG Medics S.Korea
NovatoxUse of strains identified with Clostridium botulinum ATCC 3502Securing stable production process technology by simplifying the undiluted solution manufacturing process Production of more than 99% of undiluted solutionTechnologydevelopmentcapabilitiesExpect safe product production/ management through bio factories equipped with state-of-the-art production facilitiesInstitute – 2,704 ,000 Vials can be produced annually with Botox Production Plant & Research
